Innova Captab IPO Date, Price, GMP, Review and Best 3 IPOs to Invest

Hello my fellow finance enthusiasts, there is a huge investment opportunity opening up in the near future. Yes, you heard absolutely right. The Innova Captab IPO is going to open soon. So I will give you complete information about Innova Captab IPO here on IPO India.

On this article I will inform you about Innova Captab IPO Date, Price, GMP, Review and Best 3 IPOs to Invest. So without wasting any more time let’s start.

About Innova Captab

Established in January 2005, Inova Captub Limited operates as a pharmaceutical entity with presence in three distinct business sectors. Firstly, it specializes in delivering contract development and manufacturing services to Indian pharmaceutical companies. Second, the company is involved in the domestic market, focusing on the distribution of branded generics. Finally, it operates an international business segment dedicated to the sale of branded generics.

The company’s product range includes tablets, capsules, dry syrup, dry powder injection, ointment and liquid medicines.

During the fiscal year 2023 and the three months ending June 30, 2023, Innova Captab Limited successfully manufactured and sold more than 600 different generic products. These products were marketed under the company’s proprietary brands in the Indian market using an extensive network of approximately 5,000 distributors and stockists as well as over 150,000 retail pharmacies. Additionally, during fiscal 2023 and the three months ending June 30, 2023, Innova Captab expanded its global reach by exporting branded generic products to 20 and 16 countries, respectively.

As of October 31, 2023, the company maintained a skilled team of 29 scientists and engineers in its research and development laboratory. Located in Badi, Haryana, the company’s manufacturing facility is an important component of its operational infrastructure.

Innova Captab IPO GMP

About Innova Captab IPO

Here is some information about Innova Captab IPO which will help you in making a decision to invest in Innova Captab IPO. It appears to be a book-built offer with a total value of Rs ₹570 crore, including fresh issue of Rs 320.00 crore and offer for sale of 0.56 crore shares.

Summary of the key details

• Issue Size: Rs 570 crores
• Offer for Sale: 0.56 crore shares
• Subscription Period: December 21, 2023 to December 26, 2023
• Allotment Date: December 27, 2023
• Listing Date: December 29, 2023

Price Range of Innova Captab IPO

• ₹426 to ₹448 per share

Lot Size of Innova Captab IPO

• Minimum Lot: 33 Shares.
• Minimum Investment for Retail Investors: ₹14,784

Minimum Lot Size Investments for Innova Captab IPO

• S-HNI: 14 lots (462 shares), amounting to ₹2,06,976
• B-HNI: 68 lots (2,754 shares), amounting to ₹10,05,312

This information provides potential investors with the details they need to participate in the Innova Captab IPO. It is important to note that investing in IPOs carries risks, and individuals should do their own research or consult financial professionals before making investment decisions.

To Open a trading and demat account in Zerodha

Innova Captab IPO

To know more about IPOs.

Valuations of Innova Captab IPO

Innova Captab Financial Information

Promoter(s)

Company Promotor(s):-

1. Manoj Kumar Lohariwala
2. Vinay Kumar Lohariwala

If you are new to the investment section and want to know how to invest in IPOs, you can read our article “How to Invest in IPOs?“.

Key Performance Indicator

Issue Objective(s)

• Repayment and / or Prepayment in part or in full, of certain outstanding loans of the Company
• Investing in the Subsidiary, UML, for repayment and / or prepayment in part or full of outstanding loans availed by UML
• Funding the working capital requirements
• General corporate purposes

Innova Captab IPO Registrar

Innova Captab IPO Review

Update Soon

Conclusion

For those seeking exposure to the growing pharmaceutical sector, the Innova Captab IPO beckons with a diversified business model and solid financial performance. Its domestic stronghold and expanding international reach paint a promising picture for future growth. However, the inherent risks of any IPO cannot be ignored.

Before taking the leap, consider valuations against industry peers, prevailing market conditions and the company’s financial health. Weigh the Innova Captab IPO against alternative investment options to ensure it aligns with your risk tolerance and investment goals. Ultimately, a well-informed decision, supported by thorough research, holds the key to unlocking the potential rewards of this pharmaceutical play.

Remember, while there is potential, the path to success demands a calculated approach. Invest wisely, and good luck!

Innova Captab IPO FAQs